We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Lipoprotein(a)

    Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case...

    Karam Kostner, Gerhard M. Kostner, Peter P. Toth in Contemporary Cardiology
    Book 2023
  2. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)

    Purpose of Review

    Familial hypercholesterolemia (FH) and hyperlipoproteinemia(a) are relatively common disorders, posing a significant health burden...

    Maya S. Safarova, Patrick M. Moriarty in Current Atherosclerosis Reports
    Article 05 June 2023
  3. Association between lipoprotein(a) and cardiovascular disease in patients undergoing coronary angiography

    Objective

    Many previous studies reported the relationship between lipoprotein(a) and cardiovascular disease, but the conclusions were controversial....

    Azhi ShaMa, Chunmei Xu, ... Chunyu Zeng in Herz
    Article 24 April 2024
  4. Lipoprotein glomerulopathy: a rare cause of steroid-resistant nephrotic syndrome in a child

    Lipoprotein glomerulopathy (LPG) is a rare condition of renal lipidosis characterized by lipoprotein thrombi in glomeruli, an abnormal plasma...

    Kinnari Vala, Kanisha Shah, ... Anshuman Saha in CEN Case Reports
    Article 04 March 2024
  5. Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment

    Purpose of Review

    Lipoprotein(a) is an important causal risk factor for cardiovascular disease but currently no available medication effectively...

    Anders Berg Wulff, Børge G. Nordestgaard, Anne Langsted in Current Atherosclerosis Reports
    Article 05 February 2024
  6. Therapeutic Potential of Lipoprotein(a) Inhibitors

    Increasing evidence has implicated lipoprotein(a) [Lp(a)] in the causality of atherosclerosis and calcific aortic stenosis. This has stimulated...

    Stephen J. Nicholls in Drugs
    Article Open access 08 June 2024
  7. Lipoprotein(a), platelet function and cardiovascular disease

    Lipoprotein(a) (Lp(a)) is associated with atherothrombosis through several mechanisms, including putative antifibrinolytic properties. However,...

    Harpreet S. Bhatia, Richard C. Becker, ... Sotirios Tsimikas in Nature Reviews Cardiology
    Article 08 November 2023
  8. Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation

    Introduction

    A new cardiovascular risk (CVR) calculator that incorporates Lipoprotein(a) [Lp(a)] levels has recently been designed.

    Aims ...
    Walter Masson, Gabriel Waisman, ... Daniel Siniawski in High Blood Pressure & Cardiovascular Prevention
    Article 13 May 2024
  9. Lipoprotein(a) and heart failure: a systematic review

    The role of lipoprotein(a) [Lp(a)] as a possible causal risk factor for atherosclerotic artery disease and aortic valve stenosis has been well...

    Walter Masson, Leandro Barbagelata, ... Juan P. Nogueira in Heart Failure Reviews
    Article 19 July 2023
  10. Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study

    Objective

    The relationship between the non-high-density lipoprotein to high-density lipoprotein ratio (non-HDL-c/HDL-c ratio) and changes in glycemic...

    Zihe Mo, Yong Han, ... Haofei Hu in Diabetology & Metabolic Syndrome
    Article Open access 17 December 2023
  11. Lipoprotein(a): a Case for Universal Screening in Youth

    Purpose of Review

    Lipoprotein(a) has emerged as a strong independent risk factor for cardiovascular disease. Targeted screening recommendations for...

    Aparna Alankar, Preneet C. Brar, Brenda Kohn in Current Atherosclerosis Reports
    Article 05 July 2023
  12. Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of Atherosclerosis

    Purpose of Review

    The primary objective of this review is to explore the pathophysiological roles and clinical implications of lipoprotein(a) [Lp(a)]...

    Ting Qin, Tian-Yi Ma, ... Jian-Jun Li in Current Atherosclerosis Reports
    Article Open access 15 June 2024
  13. Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes

    Purpose of Review

    Lipoprotein(a) is an independent risk factor for cardiovascular disease. We review the ongoing shifts in consensus guidelines for...

    Gary S. Ma, Tommy T. Chiou, Michael J. Wilkinson in Current Cardiology Reports
    Article Open access 26 August 2023
  14. Women and lipoprotein apheresis: another side of gender medicine

    Aim

    In heterozygous Familial Hypercholesterolemia (FH) woman atherosclerotic cardiovascular disease occurs 20-years earlier respect woman without FH...

    Beatrice Dal Pino, Francesco Sbrana in Endocrine
    Article 28 June 2024
  15. Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex

    Background

    Lipoprotein(a) (Lp(a)) is an inherited risk factor for atherosclerotic cardiovascular disease (ASCVD). Limited data exist on Lp(a) values...

    Paulina E. Stürzebecher, Konstantin L. Uttinger, ... Ulrich Laufs in Pediatric Research
    Article Open access 28 February 2024
  16. Association between serum lipoprotein(a) and mildly reduced eGFR: a cross-sectional study

    Lipoprotein(a) [Lp(a)] is a risk factor for cardiovascular disease (CVD) and aortic stenosis. However, the data on the relationship between Lp(a) and...

    Hong Zhang, Rui Chen, ... **aolin Huang in BMC Nephrology
    Article Open access 08 December 2023
  17. Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?

    Numerous genetic and epidemiologic studies have demonstrated an association between elevated levels of lipoprotein(a) (Lp[a]) and cardiovascular...

    Henriette Thau, Sebastian Neuber, ... Timo Z. Nazari-Shafti in Cardiology and Therapy
    Article Open access 21 February 2024
  18. Lipoprotein(a) im Fokus

    Eleni Pappa, Anja Vogt in CardioVasc
    Article 14 December 2023
  19. Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants

    Background

    High-density lipoprotein cholesterol’s (HDL-C) long-held status as a cardiovascular disease (CVD) preventative has been called into...

    Hye Jun Kim, Seogsong Jeong, ... Sang Min Park in Cardiovascular Diabetology
    Article Open access 28 March 2023
Did you find what you were looking for? Share feedback.